European Patent Office OKs Mouse Patent With Restrictions

Law360, New York (July 6, 2004, 12:00 AM EDT) -- The European Patent Office has upheld a Harvard University patent on a mouse genetically altered to develop cancer.

However, the office restricted its wording so that it applies only to mice and not to all species of rodents.

Using the patented technique, scientists can alter a gene in rodents and make them more likely to develop tumors. The mice are used to test whether a material might contain carcinogens.

The U.S. Patent and Trademark Office granted a patent to Harvard’s “oncomouse” in 1988, the first "transgenic"...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.